- United States
- /
- Software
- /
- NasdaqGS:MSFT
Microsoft China Patent Ruling Weighed Against Long Term Valuation Support
- Microsoft is facing a landmark patent infringement case in China's Supreme People's Court involving Newman Infinite's touchscreen and GUI patent.
- The dispute centers on alleged infringement tied to the Windows operating system and Surface hardware in one of Microsoft's most important international markets.
- Microsoft previously sought to invalidate the patent several times within China, but those efforts did not succeed, pushing the case to the country's highest court.
- The outcome could influence how software and interface patents are enforced for multinational tech firms operating in China.
For investors tracking NasdaqGS:MSFT, this case sits alongside a share price of $414.44 and mixed recent performance, with a 30 day return of 11.0% but a 1 year return decline of 4.1%. Over longer periods, Microsoft has delivered a 36.6% return over 3 years and 71.1% over 5 years, which many investors weigh against current legal and regulatory risks.
The case in China's Supreme People's Court adds another layer of legal and operational uncertainty for Microsoft in a major market, particularly around its Windows OS and Surface ecosystem. Investors will likely focus on how Microsoft manages potential outcomes, including any required product changes, licensing costs, or shifts in its China strategy if the ruling goes against the company.
Stay updated on the most important news stories for Microsoft by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Microsoft.
Quick Assessment
- ✅ Price vs Analyst Target: At US$414.44, the price is about 26% below the US$562.70 analyst target.
- ✅ Simply Wall St Valuation: The shares are flagged as trading 28.2% below estimated fair value.
- ✅ Recent Momentum: The 30 day return of 11.0% points to short term positive sentiment despite the court case.
There is only one way to know the right time to buy, sell or hold Microsoft. Head to Simply Wall St's company report for the latest analysis of Microsoft's Fair Value.
Key Considerations
- 📊 The China patent case sits against a backdrop of higher analyst targets and an internal estimate of undervaluation, so you are weighing legal uncertainty against signs of pricing support.
- 📊 Watch any disclosures on potential licensing costs, product tweaks to Windows or Surface, and whether this affects revenue or margins linked to China.
- ⚠️ The most relevant risk here is that an adverse ruling could add legal costs or constrain certain products in one of Microsoft's key international markets.
Dig Deeper
For the full picture, including more risks and rewards, check out the complete Microsoft analysis. Alternatively, you can visit the community page for Microsoft to see how other investors believe this latest news will impact the company's narrative.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About NasdaqGS:MSFT
Microsoft
Develops and supports software, services, devices, and solutions worldwide.
Very undervalued with outstanding track record and pays a dividend.
Similar Companies
Market Insights
Weekly Picks

Cue Biopharma (NASDAQ: CUE): The Scientist Behind Xolair Just Gave Cue a Next-Generation Shot at the Same Multi-Billion-Dollar Market

AST SpaceMobile: The Boldest Direct-to-Cell Bet in Public Markets
Onto Innovation: The Advanced Packaging Chokepoint 51.3% undervalued intrinsic discount

Investment Analysis (May 2026)
Recently Updated Narratives

Making sense of 1.75 trillion IPO
SpaceX? Only Fast in - Fast out!

INDIAN OIL CORPORATION IS THE TITAN IN TRANSITION
Popular Narratives

Investment Analysis (May 2026)

Take-Two Interactive: The Calm Before the Storm NASDAQ: TTWO Last Price: $242.41 Date: May 15, 2026

Honeywell - The Demand-Side of the AI Infrastructure
Trending Discussion
